Immunogenicity of BNT162b2, BBIBP-CorV, Gam-COVID-Vac and ChAdOx1 nCoV-19 Vaccines Six Months after the Second Dose: A Longitudinal Prospective Study

Many available SARS-CoV-2 vaccines demonstrated good humoral response, but studies directly comparing their immunogenicity in the general population are lacking. We evaluated the medium–term kinetics of anti-S SARS-CoV-2 antibodies (Abs) at one and six months after the second dose of BNT162b2, BBIBP...

Descripción completa

Detalles Bibliográficos
Autores principales: Petrović, Vladimir, Vuković, Vladimir, Patić, Aleksandra, Marković, Miloš, Ristić, Mioljub
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9865554/
https://www.ncbi.nlm.nih.gov/pubmed/36679901
http://dx.doi.org/10.3390/vaccines11010056

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9865554/
https://www.ncbi.nlm.nih.gov/pubmed/36679901
http://dx.doi.org/10.3390/vaccines11010056

Ejemplares similares